P-539: Is the regression of left ventricular hypertrophy accompanied by the decrease of ventricular arrhythmias?

The increase of arrhythmia of hypertensive left ventricular hypertrophy is correlated with the risk of sudden death. In antihypertensive treatment it is possible to achieve regression LVH, but it has not been proved what impact regression LVH has on arrhythmia markers. Methods: 75 patients with II-I...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:American journal of hypertension 2001-04, Vol.14 (S1), p.211A-211A
Hauptverfasser: Tasic, Ivan S., Lovic, Branko K., Ilic, Stevan B., Djordjevic, Dragan Lj, Miladinovic-Tasic, Natasa L.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 211A
container_issue S1
container_start_page 211A
container_title American journal of hypertension
container_volume 14
creator Tasic, Ivan S.
Lovic, Branko K.
Ilic, Stevan B.
Djordjevic, Dragan Lj
Miladinovic-Tasic, Natasa L.
description The increase of arrhythmia of hypertensive left ventricular hypertrophy is correlated with the risk of sudden death. In antihypertensive treatment it is possible to achieve regression LVH, but it has not been proved what impact regression LVH has on arrhythmia markers. Methods: 75 patients with II-III stage hypertension (43 male) average age 55.9 ± 8 and LVH determinated by echocardiography have been treated for a year. Arrhythmia parameters were the following: ventricular arrhythmias have been registered after 24 hour Holter monitoring and graded according to Lown; QT dispersion and heart rate variability (HRV) have been determined by time analysis from Holter monitoring. Results: After a year treatment a significant LV mass reduction (A) has been achieved in 37 patients (51%). (See Table) Variable Before Th After Th LVMI (A) (g/m2) 172 ± 35.6 142.1 ± 25* LVMI (B) (g/m2) 152.6 ± 21.3 158.7 ± 25.8 VES (Lown) (A) 2.88 ± 1.37 2 ± 1.4* VES (Lown) (B) 2.21 ± 1.7 2.1 ± 1.48 VT and couplets (A) 15 (20.5%) 6 (8.2%)* VT and couplets (B) 9 (12.3%) 7 (9,6%) QTc dispersion (A) 61.7 ± 22.4 48.3 ± 17.7* QTc dispersion (B) 48.5 ± 21.7 50.8 ± 21.2 SDNN (A) 123.3 ± 26 129.3 ± 29.1 SDNN (B) 116.5 ± 22.2± 118.4 ± 23.4 *p
doi_str_mv 10.1016/S0895-7061(01)01804-0
format Article
fullrecord <record><control><sourceid>proquest_istex</sourceid><recordid>TN_cdi_proquest_journals_1026628526</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2713067791</sourcerecordid><originalsourceid>FETCH-LOGICAL-i666-8c38626ba1161e9593991cb5c10dade9d03bea38847590d2a1b1647ddb725f5a3</originalsourceid><addsrcrecordid>eNpNjV1LwzAYRoMoOKc_QQh4oxfRvGmTNt6IDHXDMcUNEW9C2ry1ndtak07sv_djIl49N-ech5BD4KfAQZ1NeaolS7iCYw4nHFIeM75FeqBjYIkQcpv0_pBdshfCnHMeKwU90twzGelzOgq0LZF6fPEYQlWvaF3QBRYtfcdV66t8vbCell2DvvV1U3bU5nm9bOyqQkez7sd2mHu0Ab_d_5r1vuzaclnZcLFPdgq7CHjwu30yu76aDYZsfHczGlyOWaWUYmkepUqozAIoQC11pDXkmcyBO-tQOx5laKM0jROpuRMWMlBx4lyWCFlIG_XJ0Sbb-PptjaE183rtV1-PBrhQSqRSqC-KbagqtPhhGl8tre-M9a9GJVEizfDp2TzcTrWeTCfmMfoEVe5sbA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1026628526</pqid></control><display><type>article</type><title>P-539: Is the regression of left ventricular hypertrophy accompanied by the decrease of ventricular arrhythmias?</title><source>Oxford University Press Journals All Titles (1996-Current)</source><source>Alma/SFX Local Collection</source><creator>Tasic, Ivan S. ; Lovic, Branko K. ; Ilic, Stevan B. ; Djordjevic, Dragan Lj ; Miladinovic-Tasic, Natasa L.</creator><creatorcontrib>Tasic, Ivan S. ; Lovic, Branko K. ; Ilic, Stevan B. ; Djordjevic, Dragan Lj ; Miladinovic-Tasic, Natasa L.</creatorcontrib><description>The increase of arrhythmia of hypertensive left ventricular hypertrophy is correlated with the risk of sudden death. In antihypertensive treatment it is possible to achieve regression LVH, but it has not been proved what impact regression LVH has on arrhythmia markers. Methods: 75 patients with II-III stage hypertension (43 male) average age 55.9 ± 8 and LVH determinated by echocardiography have been treated for a year. Arrhythmia parameters were the following: ventricular arrhythmias have been registered after 24 hour Holter monitoring and graded according to Lown; QT dispersion and heart rate variability (HRV) have been determined by time analysis from Holter monitoring. Results: After a year treatment a significant LV mass reduction (A) has been achieved in 37 patients (51%). (See Table) Variable Before Th After Th LVMI (A) (g/m2) 172 ± 35.6 142.1 ± 25* LVMI (B) (g/m2) 152.6 ± 21.3 158.7 ± 25.8 VES (Lown) (A) 2.88 ± 1.37 2 ± 1.4* VES (Lown) (B) 2.21 ± 1.7 2.1 ± 1.48 VT and couplets (A) 15 (20.5%) 6 (8.2%)* VT and couplets (B) 9 (12.3%) 7 (9,6%) QTc dispersion (A) 61.7 ± 22.4 48.3 ± 17.7* QTc dispersion (B) 48.5 ± 21.7 50.8 ± 21.2 SDNN (A) 123.3 ± 26 129.3 ± 29.1 SDNN (B) 116.5 ± 22.2± 118.4 ± 23.4 *p&lt;0.05; A: patients with significant LV mass reduction; B: patients with non significant LV mass reduction Conclusion: In patients with significant LV mass reduction significant decrease of ventricular arrhythmias frequency and QT dispersion have been achieved while heart rate variability has improved but not significantly.</description><identifier>ISSN: 0895-7061</identifier><identifier>EISSN: 1941-7225</identifier><identifier>DOI: 10.1016/S0895-7061(01)01804-0</identifier><identifier>CODEN: AJHYE6</identifier><language>eng</language><publisher>Oxford: Oxford University Press</publisher><subject>arrhythmias ; hypertension ; hypertrophy</subject><ispartof>American journal of hypertension, 2001-04, Vol.14 (S1), p.211A-211A</ispartof><rights>Copyright Nature Publishing Group Apr 2001</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27903,27904</link.rule.ids></links><search><creatorcontrib>Tasic, Ivan S.</creatorcontrib><creatorcontrib>Lovic, Branko K.</creatorcontrib><creatorcontrib>Ilic, Stevan B.</creatorcontrib><creatorcontrib>Djordjevic, Dragan Lj</creatorcontrib><creatorcontrib>Miladinovic-Tasic, Natasa L.</creatorcontrib><title>P-539: Is the regression of left ventricular hypertrophy accompanied by the decrease of ventricular arrhythmias?</title><title>American journal of hypertension</title><addtitle>AJH</addtitle><description>The increase of arrhythmia of hypertensive left ventricular hypertrophy is correlated with the risk of sudden death. In antihypertensive treatment it is possible to achieve regression LVH, but it has not been proved what impact regression LVH has on arrhythmia markers. Methods: 75 patients with II-III stage hypertension (43 male) average age 55.9 ± 8 and LVH determinated by echocardiography have been treated for a year. Arrhythmia parameters were the following: ventricular arrhythmias have been registered after 24 hour Holter monitoring and graded according to Lown; QT dispersion and heart rate variability (HRV) have been determined by time analysis from Holter monitoring. Results: After a year treatment a significant LV mass reduction (A) has been achieved in 37 patients (51%). (See Table) Variable Before Th After Th LVMI (A) (g/m2) 172 ± 35.6 142.1 ± 25* LVMI (B) (g/m2) 152.6 ± 21.3 158.7 ± 25.8 VES (Lown) (A) 2.88 ± 1.37 2 ± 1.4* VES (Lown) (B) 2.21 ± 1.7 2.1 ± 1.48 VT and couplets (A) 15 (20.5%) 6 (8.2%)* VT and couplets (B) 9 (12.3%) 7 (9,6%) QTc dispersion (A) 61.7 ± 22.4 48.3 ± 17.7* QTc dispersion (B) 48.5 ± 21.7 50.8 ± 21.2 SDNN (A) 123.3 ± 26 129.3 ± 29.1 SDNN (B) 116.5 ± 22.2± 118.4 ± 23.4 *p&lt;0.05; A: patients with significant LV mass reduction; B: patients with non significant LV mass reduction Conclusion: In patients with significant LV mass reduction significant decrease of ventricular arrhythmias frequency and QT dispersion have been achieved while heart rate variability has improved but not significantly.</description><subject>arrhythmias</subject><subject>hypertension</subject><subject>hypertrophy</subject><issn>0895-7061</issn><issn>1941-7225</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2001</creationdate><recordtype>article</recordtype><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNpNjV1LwzAYRoMoOKc_QQh4oxfRvGmTNt6IDHXDMcUNEW9C2ry1ndtak07sv_djIl49N-ech5BD4KfAQZ1NeaolS7iCYw4nHFIeM75FeqBjYIkQcpv0_pBdshfCnHMeKwU90twzGelzOgq0LZF6fPEYQlWvaF3QBRYtfcdV66t8vbCell2DvvV1U3bU5nm9bOyqQkez7sd2mHu0Ab_d_5r1vuzaclnZcLFPdgq7CHjwu30yu76aDYZsfHczGlyOWaWUYmkepUqozAIoQC11pDXkmcyBO-tQOx5laKM0jROpuRMWMlBx4lyWCFlIG_XJ0Sbb-PptjaE183rtV1-PBrhQSqRSqC-KbagqtPhhGl8tre-M9a9GJVEizfDp2TzcTrWeTCfmMfoEVe5sbA</recordid><startdate>200104</startdate><enddate>200104</enddate><creator>Tasic, Ivan S.</creator><creator>Lovic, Branko K.</creator><creator>Ilic, Stevan B.</creator><creator>Djordjevic, Dragan Lj</creator><creator>Miladinovic-Tasic, Natasa L.</creator><general>Oxford University Press</general><scope>BSCLL</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope></search><sort><creationdate>200104</creationdate><title>P-539: Is the regression of left ventricular hypertrophy accompanied by the decrease of ventricular arrhythmias?</title><author>Tasic, Ivan S. ; Lovic, Branko K. ; Ilic, Stevan B. ; Djordjevic, Dragan Lj ; Miladinovic-Tasic, Natasa L.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-i666-8c38626ba1161e9593991cb5c10dade9d03bea38847590d2a1b1647ddb725f5a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2001</creationdate><topic>arrhythmias</topic><topic>hypertension</topic><topic>hypertrophy</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Tasic, Ivan S.</creatorcontrib><creatorcontrib>Lovic, Branko K.</creatorcontrib><creatorcontrib>Ilic, Stevan B.</creatorcontrib><creatorcontrib>Djordjevic, Dragan Lj</creatorcontrib><creatorcontrib>Miladinovic-Tasic, Natasa L.</creatorcontrib><collection>Istex</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><jtitle>American journal of hypertension</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Tasic, Ivan S.</au><au>Lovic, Branko K.</au><au>Ilic, Stevan B.</au><au>Djordjevic, Dragan Lj</au><au>Miladinovic-Tasic, Natasa L.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>P-539: Is the regression of left ventricular hypertrophy accompanied by the decrease of ventricular arrhythmias?</atitle><jtitle>American journal of hypertension</jtitle><addtitle>AJH</addtitle><date>2001-04</date><risdate>2001</risdate><volume>14</volume><issue>S1</issue><spage>211A</spage><epage>211A</epage><pages>211A-211A</pages><issn>0895-7061</issn><eissn>1941-7225</eissn><coden>AJHYE6</coden><abstract>The increase of arrhythmia of hypertensive left ventricular hypertrophy is correlated with the risk of sudden death. In antihypertensive treatment it is possible to achieve regression LVH, but it has not been proved what impact regression LVH has on arrhythmia markers. Methods: 75 patients with II-III stage hypertension (43 male) average age 55.9 ± 8 and LVH determinated by echocardiography have been treated for a year. Arrhythmia parameters were the following: ventricular arrhythmias have been registered after 24 hour Holter monitoring and graded according to Lown; QT dispersion and heart rate variability (HRV) have been determined by time analysis from Holter monitoring. Results: After a year treatment a significant LV mass reduction (A) has been achieved in 37 patients (51%). (See Table) Variable Before Th After Th LVMI (A) (g/m2) 172 ± 35.6 142.1 ± 25* LVMI (B) (g/m2) 152.6 ± 21.3 158.7 ± 25.8 VES (Lown) (A) 2.88 ± 1.37 2 ± 1.4* VES (Lown) (B) 2.21 ± 1.7 2.1 ± 1.48 VT and couplets (A) 15 (20.5%) 6 (8.2%)* VT and couplets (B) 9 (12.3%) 7 (9,6%) QTc dispersion (A) 61.7 ± 22.4 48.3 ± 17.7* QTc dispersion (B) 48.5 ± 21.7 50.8 ± 21.2 SDNN (A) 123.3 ± 26 129.3 ± 29.1 SDNN (B) 116.5 ± 22.2± 118.4 ± 23.4 *p&lt;0.05; A: patients with significant LV mass reduction; B: patients with non significant LV mass reduction Conclusion: In patients with significant LV mass reduction significant decrease of ventricular arrhythmias frequency and QT dispersion have been achieved while heart rate variability has improved but not significantly.</abstract><cop>Oxford</cop><pub>Oxford University Press</pub><doi>10.1016/S0895-7061(01)01804-0</doi></addata></record>
fulltext fulltext
identifier ISSN: 0895-7061
ispartof American journal of hypertension, 2001-04, Vol.14 (S1), p.211A-211A
issn 0895-7061
1941-7225
language eng
recordid cdi_proquest_journals_1026628526
source Oxford University Press Journals All Titles (1996-Current); Alma/SFX Local Collection
subjects arrhythmias
hypertension
hypertrophy
title P-539: Is the regression of left ventricular hypertrophy accompanied by the decrease of ventricular arrhythmias?
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-23T20%3A56%3A09IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_istex&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=P-539:%20Is%20the%20regression%20of%20left%20ventricular%20hypertrophy%20accompanied%20by%20the%20decrease%20of%20ventricular%20arrhythmias?&rft.jtitle=American%20journal%20of%20hypertension&rft.au=Tasic,%20Ivan%20S.&rft.date=2001-04&rft.volume=14&rft.issue=S1&rft.spage=211A&rft.epage=211A&rft.pages=211A-211A&rft.issn=0895-7061&rft.eissn=1941-7225&rft.coden=AJHYE6&rft_id=info:doi/10.1016/S0895-7061(01)01804-0&rft_dat=%3Cproquest_istex%3E2713067791%3C/proquest_istex%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1026628526&rft_id=info:pmid/&rfr_iscdi=true